Provider
HIMSS24
Jorie AI CEO Sal Lo discusses his company's product that helps reduce administrative workload and enables healthcare organizations to speed up eligibility verification and claims processing.
The virtual care company will be directly available to patients experiencing menopause and perimenopause or via a Keck Medicine of USC-affiliated provider.
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
Cyberwrite President Hartmut Mai discusses the Change Healthcare ransomware attack and how chain reaction cyberattacks could affect cyber insurance opportunities.
HIMSS24
Dr. Nada Milosavljevic, Safe Health CMO and 2024 HIMSS Changemaker Award recipient, offers advice on collaborating with people from different backgrounds and becoming comfortable with challenges while working in the healthcare innovation space.
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
The company will use the funds to scale its growth within healthcare systems and expand its AI innovation.
Dr. Yusuf Sherwani, CEO and cofounder of Pelago, describes how the company partners with employers and health plans to control the costs of substance misuse disorders and the effectiveness of the virtual evidence-based treatment platform.
HIMSS24
US Health and Human Services CISO La Monte Yarborough discusses the HHS 405(d) program, which provides free educational resources and cybersecurity best practices in English and Spanish for healthcare organizations of all sizes.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.